1 report for “Research invitations”

FDA OCET Overview of the BAA — selected contract metadata, December 6, 2022

Robert Orr, U.S. Food and Drug Administration. fda.gov. December 6, 2022.

Robert Orr’s FDA presentation publicly describes a 2017 modification of contract HHSF223201610018C and links 75F40120C00176 to a collaboration studying COVID-19 illness in diverse populations. These identifiers match contracts acknowledged for Nolan in MaxFuse. The slides document agency statements about public research funding; they do not name Nolan or establish secret invitations or UAP access.